Table 5.
Association of FVII polymorphism with warfarin sensitivity during the maintenance phase of therapy of 129 cardiovascular patients
| Gene | Genotype | Sensitive | Moderate | Resistance | P-valuea |
|---|---|---|---|---|---|
|
| |||||
| FVII | H5H5 | 1/6 (16.7%) | 4/6 (66.6%) | 1/6 (16.7%) | 0.265 |
| H6H6 | 10/59 (17.0%) | 36/59 (61.0%) | 13/59 (22.0%) | ||
| H7H7 | 2/14 (14.3%) | 11/14 (78.6%) | 1/14 (7.1%) | ||
| H8H8 | 0/2 (0.0%) | 0/2 (0.0%) | 2/2 (100%) | ||
| H6H7 | 4/45 (8.9%) | 27/45 (60.0%) | 14/45 (31.1%) | ||
| H5H6 | 1/3 (33.3%) | 2/3 (66.7%) | 0/3 (0.0%) | ||
Note:
a
Fisher’s exact test with P<0.05 is considered significant.